Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.24 EUR | +0.31% | +0.21% | -4.28% |
Mar. 28 | LNA Santé: 9% drop in annual RNPG | CF |
Feb. 12 | LNA Santé: LNA Ensemble exceeds 10% of voting rights | CF |
Strengths
- Its low valuation, with P/E ratio at 8.29 and 9.12 for the ongoing fiscal year and 2024 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company does not generate enough profits, which is an alarming weak point.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.28% | 210M | C+ | ||
-14.92% | 84.68B | B- | ||
+13.30% | 81.12B | C+ | ||
+11.62% | 29.4B | C+ | ||
-12.71% | 16.73B | B | ||
-3.06% | 16.36B | A- | ||
-2.63% | 14.92B | A- | ||
-31.75% | 11.77B | - | - | |
-1.42% | 11.72B | A- | ||
+27.44% | 11.71B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LNA Stock
- Ratings LNA Santé